Amgen Inc. filed an 8-K disclosing a material cybersecurity incident in July 2026 involving unauthorized access to third-party cloud environments. Proprietary data and patient protected health information (PHI) were exfiltrated. The investigation is ongoing, and the company has engaged forensic experts and implemented containment measures. No impact to manufacturing or financial reporting was identified.